Published in
Elsevier, European Journal of Cancer, (47), p. S420
DOI: 10.1016/s0959-8049(11)71741-5
Links
Tools
6096 POSTER FOLFOXIRI (Irinotecan, Oxaliplatin, and Infusional 5FU/LV) in Combination With Panitumumab (P) in the First-line Treatment of Metastatic Colorectal Cancer (mCRC) Patients (pts) Selected for KRAS, BRAF, NRas and HRas Mutational Status – a Phase II Study by the G.O.N.O. Group
Journal article published in 2011 by
L. Fornaro,
F. Loupakis,
S. Lonardi,
G. Masi,
L. Salvatore 
,
C. Cremolini,
F. Bergamo,
A. Cappetta,
V. Zagonel,
A. Falcone
,
C. Cremolini,
F. Bergamo,
A. Cappetta,
V. Zagonel,
A. Falcone
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 